Aldosterone Producing Adrenocortical Carcinoma: A Case Report and Systematic Review of the Rare Disease

Aldosterone Producing Adrenocortical Carcinoma: A Case Report and Systematic Review of the Rare Disease

bikash_bikram_thapa

Contact

Bikash Bikram Thapa

Contact

Bina Basnet

Contact

Tribhuvan University

Aldosterone Producing Adrenocortical Carcinoma: A Case Report and Systematic Review of the Rare Disease

Article Fingerprint

ReserarchID

L55B4

Aldosterone Producing Adrenocortical Carcinoma: A Case Report and Systematic Review of the Rare Disease Banner

AI TAKEAWAY

Connecting with the Eternal Ground

References

50 Cites in Article

Reference Format

Martin Fassnacht,Wiebke Arlt,Irina Bancos,Henning Dralle,John Newell-Price,Anju Sahdev,Antoine Tabarin,Massimo Terzolo,Stylianos Tsagarakis,Olaf Dekkers (2016). Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.
Y Reznik,H Lefebvre,V Rohmer,B Charbonnel,A Tabarin,P Rodien,P Lecomte,S Bardet,C Coffin,J Mahoudeau (2004). Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.
T Cawood,P Hunt,O' Shea,D Cole,D Soule,S (2009). Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?.
F Mantero,M Terzolo,G Arnaldi,G Osella,A Masini,A Ali,M Giovagnetti,G Opocher,A Angeli (2000). A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology.
Linda Ng,John Libertino (2003). Adrenocortical Carcinoma: Diagnosis, Evaluation and Treatment.
Marc Wooten,David King (1993). Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature.
John Funder,Robert Carey,Carlos Fardella,Celso Gomez-Sanchez,Franco Mantero,Michael Stowasser,William Young,Victor Montori (2008). Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline.
H Umakoshi,R Sakamoto,Y Matsuda,M Yokomoto-Umakoshi,H Nagata,T Fukumoto,M Ogata,Y Ogawa (2020). Role of Aldosterone and Potassium Levels in Sparing Confirmatory Tests in Primary Aldosteronism.
Paul Stewart (1999). Mineralocorticoid hypertension.
Teresa Seccia,Ambrogio Fassina,Gastone Nussdorfer,Achille Pessina,Gian Rossi (2005). Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn’s syndrome with an ominous clinical course.
Jerome Conn,Ralph Knopf,Reed Nesbit (1964). Clinical characteristics of primary aldosteronism from an analysis of 145 cases.
Isobel Mouat,Kei Omata,Andrew Mcdaniel,Namita Hattangady,Debnita Talapatra,Andi Cani,Daniel Hovelson,Scott Tomlins,William Rainey,Gary Hammer,Thomas Giordano,Tobias Else (2019). Somatic mutations in adrenocortical carcinoma with primary aldosteronism or hyperreninemic hyperaldosteronism.
Michael Kendrick,Kathleen Curlee,Ricardo Lloyd,David Farley,Clive Grant,Geoffrey Thompson,Charles Rowland,William Young,Jon Van Heerden (2002). Aldosterone-secreting adrenocortical carcinomas are associated with unique operative risks and outcomes.
D Henley,J Van Heerden,C Grant,J Carney,P Carpenter (1983). Adrenal cortical carcinoma--a continuing challenge.
Richard Schulick,Murray Brennan (1999). Adrenocortical carcinoma.
Nicholas Tritos,Gary Cushing,Gerald Heatley,John Libertino (2000). Clinical Features and Prognostic Factors Associated with Adrenocortical Carcinoma: Lahey Clinic Medical Center Experience.
Cecilia Mattsson,William Young (2006). Primary aldosteronism: diagnostic and treatment strategies.
A Angeli,G Osella,A Ali,M Terzolo (1997). Adrenal Incidentaloma: An Overview of Clinical and Epidemiological Data from the National Italian Study Group.
Dieter Szolar,Melvyn Korobkin,Pia Reittner,Andrea Berghold,Thomas Bauernhofer,Harald Trummer,Helmut Schoellnast,Klaus Preidler,Hellmuth Samonigg (2005). Adrenocortical Carcinomas and Adrenal Pheochromocytomas: Mass and Enhancement Loss Evaluation at Delayed Contrast-enhanced CT.
Amir Hamrahian,Adriana Ioachimescu,Erick Remer,Gaspar Motta-Ramirez,Hari Bogabathina,Howard Levin,Sethu Reddy,Inderbir Gill,Allan Siperstein,Emmanuel Bravo (2005). Clinical Utility of Noncontrast Computed Tomography Attenuation Value (Hounsfield Units) to Differentiate Adrenal Adenomas/Hyperplasias from Nonadenomas: Cleveland Clinic Experience.
Danae Delivanis,Irina Bancos,Thomas Atwell,Grant Schmit,Patrick Eiken,Neena Natt,Dana Erickson,Spyridoula Maraka,William Young,Mark Nathan (2018). Diagnostic performance of unenhanced computed tomography and <sup>18</sup>F‐fluorodeoxyglucose positron emission tomography in indeterminate adrenal tumours.
Cord Sturgeon,Wen Shen,Orlo Clark,Quan-Yang Duh,Electron Kebebew (2006). Risk Assessment in 457 Adrenal Cortical Carcinomas: How Much Does Tumor Size Predict the Likelihood of Malignancy?.
M Kempers,J Lenders,L Van Outheusden,G Van Der Wilt,Schultze Kool,L Hermus,A Deinum,J (2009). Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism.
Vivien Lim,Qinghua Guo,Clive Grant,Geoffrey Thompson,Melanie Richards,David Farley,William Young (2014). Accuracy of Adrenal Imaging and Adrenal Venous Sampling in Predicting Surgical Cure of Primary Aldosteronism.
Ur Metser,Einat Even-Sapir (2006). The Role of 18F-FDG PET/CT in the Evaluation of Solid Splenic Masses.
M Boscaro,F Fallo,L Barzon,Daniele Sonino,N (1995). Adrenocortical carcinoma: epidemiology and natural history.
Philippe Icard,Pierre Goudet,Cyril Charpenay,Bernard Andreassian,Bruno Carnaille,Yves Chapuis,Patrick Cougard,Jean‐françois Henry,Charles Proye (1992). Adrenocortical carcinomas: surgical trends and results of a 253‐patient series from the French Association of Endocrine Surgeons study group.
S Aubert,A Wacrenier,X Leroy,P Devos,B Carnaille,C Proye,J Wemeau,M Lecomte-Houcke,E Leteurtre (2002). Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors.
G Rossi,R Vendraminelli,M Cesari,A Pessina (2000). A thoracic mass with hypertension and hypokalaemia.
S Deckers,L Derdelinckx,V Col,J Hamels,D Maiter (1999). Peritoneal carcinomatosis following laparoscopic resection of an adrenocortical tumor causing primary hyperaldosteronism.
Sean Lau,Lawrence Weiss (2009). The Weiss system for evaluating adrenocortical neoplasms: 25 years later.
Martin Fassnacht,Bruno Allolio (2009). Clinical management of adrenocortical carcinoma.
Martin Fassnacht,Sarah Johanssen,Marcus Quinkler,Peter Bucsky,Holger Willenberg,Felix Beuschlein,Massimo Terzolo,Hans‐helge Mueller,Stefanie Hahner,Bruno Allolio (2009). Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma.
B Allolio,M Fassnacht (2006). Clinical review: Adrenocortical carcinoma: clinical update.
Martin Fassnacht,Olaf Dekkers,Tobias Else,Eric Baudin,Alfredo Berruti,Ronald De Krijger,Harm Haak,Radu Mihai,Guillaume Assie,Massimo Terzolo (2018). European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
Bruno Allolio,Stefanie Hahner,Dirk Weismann,Martin Fassnacht (2004). Management of adrenocortical carcinoma.
Joachim Reibetanz,Christian Jurowich,Ilknur Erdogan,Christoph Nies,Nada Rayes,Henning Dralle,Matthias Behrend,Bruno Allolio,Martin Fassnacht (2012). Impact of Lymphadenectomy on the Oncologic Outcome of Patients With Adrenocortical Carcinoma.
D Schteingart,G Doherty,P Gauger,T Giordano,G Hammer,M Korobkin,F Worden (2005). Management of patients with adrenal cancer: recommendations of an international consensus conference.
Francesco Porpiglia,Barbra Miller,Matteo Manfredi,Cristian Fiori,Gerard Doherty (2011). A debate on laparoscopic versus open adrenalectomy for adrenocortical carcinoma.
David Brix,Bruno Allolio,Wiebke Fenske,Ayman Agha,Henning Dralle,Christian Jurowich,Peter Langer,Thomas Mussack,Christoph Nies,Hubertus Riedmiller,Martin Spahn,Dirk Weismann,Stefanie Hahner,Martin Fassnacht (2010). Laparoscopic Versus Open Adrenalectomy for Adrenocortical Carcinoma: Surgical and Oncologic Outcome in 152 Patients.
G Sgourakis,S Lanitis,A Kouloura,P Zaphiriadou,K Karkoulias,D Raptis,A Anagnostara,C Caraliotas (2015). Laparoscopic versus Open Adrenalectomy for Stage I/II Adrenocortical Carcinoma: Meta-Analysis of Outcomes.
Alexander Stojadinovic,Ronald Ghossein,Axel Hoos,Aviram Nissan,David Marshall,Maria Dudas,Carlos Cordon-Cardo,David Jaques,Murray Brennan (2002). Adrenocortical Carcinoma: Clinical, Morphologic, and Molecular Characterization.
Aubrey Hough,John Hollifield,David Page,William Hartmann (1979). Prognostic Factors in Adrenal Cortical Tumors: A Mathematical Analysis of Clinical and Morphologic Data.
Barbra Miller,Paul Gauger,Gary Hammer,Thomas Giordano,Gerard Doherty (2010). Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade.
R Pommier,M Brennan (1992). An eleven-year experience with adrenocortical carcinoma.
A Calabrese,V Basile,S Puglisi,P Perotti,A Pia,L Saba,P Berchialla,F Porpiglia,A Veltri,M Volante,G Reimondo,A Berruti,M Terzolo (2019). Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence.
(2021). The National Comprehensive Cancer Network (NCCN) has announced updates to the NCCN Clinical Practice Guidelines in Oncology.
Tanweera Khan,Anders Sundin,Claes Juhlin,Erik Wilander,Kjell Öberg,Barbro Eriksson (2004). Vincristine, Cisplatin, Teniposide, and Cyclophosphamide Combination in the Treatment of Recurrent or Metastatic Adrenocortical Cancer.
Stephen Williamson,Danika Lew,Gary Miller,Stanley Balcerzak,Laurence Baker,E Crawford (2000). Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma.
M Fassnacht,B Allolio (2010). What is the best approach to an apparently nonmetastatic adrenocortical carcinoma?.

Download References

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

bikash_bikram_thapa. 2021. \u201cAldosterone Producing Adrenocortical Carcinoma: A Case Report and Systematic Review of the Rare Disease\u201d. Unknown Journal GJMR-I Volume 21 (GJMR Volume 21 Issue I1): .

More Citation Formats

Select Citation Style:

Download Citation

Download Article

GJMR Volume 21 Issue I1
Pg. 29- 37

Explore Journals Explore Volume Read This Issue

Journal Specifications

Keywords

Not Found

Classification

GJMR-I Classification: NLMC Code: WP 460

Submission ReceivedSeptember 8, 2021
Peer Review Double Blind
Handling Editor
Accepted October 1, 2021
Published October 15, 2021

Version of record

v1.2

Issue date

April 9, 2021

Language

Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

View in VR

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

View in 3D

Article Matrices

Total Views: 2208

Total Downloads: 1016

2026 Trends

Published Article

Abstract not found

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]